San Antonio, TXNCT05351801Now EnrollingIRB Ready

Neuropathic Pain Clinical Trial in San Antonio, TX

Access cutting-edge neuropathic pain treatment through this phase 2 clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.

Sponsored by VA Office of Research and Development

Quick Self-Assessment

See if you qualify for this San Antonio location

Preparing your pre-screening questions…

Expert Care in San Antonio

Access neuropathic pain specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neuropathic pain treatment provided free

Apply for This San Antonio Location

Check if you qualify for this neuropathic pain clinical trial in San Antonio, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Antonio

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Antonio site if eligible
  4. 4Begin participation

About This Neuropathic Pain Study in San Antonio

Chronic neuropathic pain (CNP) is disabling. Research on frontline treatments for CNP, shows inconsistent outcomes and dissatisfaction among Veterans. Veterans and clinicians have shown significant interest in cannabis derivatives (THC, CBD) for neuropathic pain control, but there are no well-controlled trials guiding expectations for benefit and adverse outcomes associated with cannabis for CNP. Because Veterans are likely to present with pain and pain-related polymorbidity significantly differ

Sponsor: VA Office of Research and Development

Who Can Participate

Inclusion Criteria

Able to provide written consent
Veterans 21 years and older at the date of screening
Meet diagnostic criteria for neuropathic pain as defined by the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain (NeuPSIG)
Meet criteria for persistent, high-impact pain criteria.
Presence of allodynia confirmed by one of the screening dynamic brush tests
women of childbearing potential who agree to abide by contraceptive requirements

Exclusion Criteria

Actively engaged in or planning to enter a program of non-pharmacological invasive intervention for pain at the time of enrollment
Peripheral neuropathy is not a primary source of neuropathic pain
Hypersensitivity to THC, CBD, or THC/CBD
Self-report of cannabis use during screening phase confirmed by positive urine toxicology for THC-COOH as measured and resulted at visit 5 before randomization
Unwilling to refrain from using cannabis or cannabis-based products through the entire duration of the study
Diagnosis of DSM-5 Cannabis Use Disorder in the past 6 months
Current DSM-5 diagnosis of cannabis use disorder, substance use disorder or serious psychiatric disorders
Actual change or intent to change is greater than a 20% change (increase or decrease) in any other medication for pain or non-pharmacological treatment from 4 weeks before the screening appointment until completion of study (i.e., visit 13)
Opioid doses \> 400 mg MME (morphine milligram equivalent)
Women who are pregnant or breastfeeding, or who intend to become pregnant in the 12 weeks from enrollment
Any current unstable or concerning medical condition that would place the patient at increased risk, including hepatic, respiratory, immunological, cardiovascular, endocrine, or renal disease, or in the opinion of the investigator, prevents adherence with the protocol
Need for immediate psychiatric hospitalization
Enrolled in a medical marijuana program
Federal employee

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Antonio?

Yes, this clinical trial (NCT05351801) has an active research site in San Antonio, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neuropathic Pain Treatment Options in San Antonio, TX

If you're searching for neuropathic pain treatment options in San Antonio, TX, this clinical trial (NCT05351801) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Antonio research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced neuropathic pain specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neuropathic pain clinical trials near you to find additional studies recruiting in your area.

More Neuropathy Trials in San Antonio, TX

See all neuropathy clinical trials recruiting in San Antonio — not just this study.

Browse Neuropathy Trials in San Antonio →

Browse More Trials by Condition

Neuropathy TrialsChronic Pain TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in San Antonio?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Antonio, TX